No way [Dissolution / BCS / IVIVC]

posted by yuvaneshwari – India, 2019-01-28 05:16 (1089 d 06:51 ago) – Posting: # 19815
Views: 1,925

Thanks for your response. I was hoping to justify the waiver on the basis of sameness of finished test product against reference. I understand that criticality still remain since the molecule is BCS II drug. Thank you.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]

Complete thread:

Activity
 Admin contact
21,833 posts in 4,568 threads, 1,554 registered users;
online 9 (1 registered, 8 guests [including 5 identified bots]).
Forum time: Friday 12:07 CET (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5